跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Astrofen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Astrofen
Approved
STANDARD
Astrofen
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4d341ccb6788e6c0
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
4d341ccb6788e6c0
Drug Approval Philippines Name
Astrofen
Product Name
Astrofen
Registration Number
DRP-3562-04
Brand Name
Astrofen
Generic Name
Ibuprofen
Dosage Form
Suspension
Dosage Strength
200 mg/5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Solvang Pharmaceuticals, Inc.
Distributor
Nurturemed Pharma Inc
Issuance Date
25 March 2025
Expiry Date
25 March 2031
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (Propionic Acid Derivative)
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4d341ccb6788e6c0
Type
Standard
Back to Philippines FDA Approvals